To test whether the antiserum would be applicable to clinicopathological examination of aromatase in breast cancer tissues, we conducted a preliminary immunohistochemical analyses in the tissue microarrays constructed with our invasive breast cancer cases. The gene discussed is CYP19A1; the disease is invasive breast carcinoma.